Immunoreactive trypsinogen levels in pediatric patients with intestinal failure awaiting intestinal transplantation

G M Rovera1, L Sigurdsson, J Reyes

  • 1Department of Pediatrics, Children's Hospital of Pittsburgh, and Starzl Transplantation Institute, University of Pittsburgh Medical Center, PA 15213-2583, USA.

Clinical Transplantation
|October 9, 1999
PubMed

Insights

Elevated immunoreactive trypsinogen (IRT) levels are common in children with intestinal failure. However, these IRT levels do not predict post-transplant pancreatitis risk in these patients.

Area of Science:

  • Pediatric Gastroenterology
  • Pancreatic Physiology
  • Intestinal Failure Research

Background:

  • Children with permanent intestinal failure often require total parenteral nutrition (TPN).
  • Assessing pancreatic function is crucial in managing these complex pediatric cases.
  • Elevated immunoreactive trypsinogen (IRT) may indicate pancreatic stress or dysfunction.

Purpose of the Study:

  • To evaluate pancreatic function in TPN-dependent children with permanent intestinal failure.
  • To assess the utility of measuring immunoreactive trypsinogen (IRT) levels.
  • To determine if IRT levels can predict post-transplant pancreatitis.

Main Methods:

  • Retrospective analysis of serum samples from 55 pediatric patients with permanent intestinal failure.
  • Measurement of immunoreactive trypsinogen (IRT) levels.
  • Comparison of IRT levels between patients with short bowel syndrome (SBS) and controls.

Main Results:

  • IRT levels were significantly higher in SBS patients compared to controls (p < 0.001).
  • IRT levels did not correlate with liver injury, bowel length, or SBS etiology.
  • Five of 20 intestinal transplant recipients developed pancreatitis post-operatively; IRT levels did not predict this.

Conclusions:

  • Elevated plasma IRT levels are frequent in children with intestinal failure.
  • IRT levels are not a reliable predictor of post-transplant pancreatitis in this population.
  • Further research is needed to identify reliable biomarkers for pancreatitis risk.

Related Concept Videos